País: Australia
Idioma: inglés
Fuente: Department of Health (Therapeutic Goods Administration)
Tranylcypromine sulfate; tranylcypromine
Mercury Pharma Australia Pty Ltd
Medicine Registered
PARNATE CONSUMER MEDICINE INFORMATION Version 3.1 Page 1 of 8 PARNATE ® TABLETS (Tranylcypromine 10 mg) CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some of the common questions about Parnate. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. Please read this leaflet before you start taking Parnate. If you are helping someone else take Parnate, please read this leaflet before you give the first dose. All medicines have risks and benefits. Your doctor has weighed the possible risks of taking Parnate against the expected benefits. Keep this leaflet with the medicine. You may want to read it again. WHAT PARNATE IS USED FOR The name of your medicine is Parnate, also known as tranylcypromine. There are many different types of medicines used to treat depression. Parnate belongs to a group of medicines called monoamine oxidase inhibitor (MAOI) antidepressants. Depression is longer lasting or more severe than the ‘low moods’ that everyone has from time to time. It is thought to be caused by a chemical imbalance in parts of the brain. The imbalance affects your whole body and can cause emotional and physical symptoms. You may feel low in spirit, lose interest in usual activities, be unable to enjoy life, have poor appetite or overeat, have disturbed sleep, often waking up early, low energy and feel guilty over nothing. Parnate corrects the chemical imbalance and so helps relieve the symptoms of depression. Your doctor may have prescribed Parnate for another use. Ask your doctor if you have questions about why Parnate has been prescribed for you. PARNATE CONSUMER MEDICINE INF Leer el documento completo
PARNATE PRODUCT INFORMATION 1 of 9 Version 2.1 NAME OF THE MEDICINE Tranylcypromine sulfate CAS no: 13492-01-8 DESCRIPTION Parnate tablets are ‘geranium rose’ coloured, biconvex film-coated tablets. Each tablet contains tranylcypromine 10 mg as the sulphate. Parnate tablets also contain the following excipients: calcium sulfate, starch - maize, sucrose, erythrosine CI45430, magnesium stearate, gelatin, Opadry complete film coating system 06H250000 Red, carnauba wax. Tranylcypromine sulphate is a white or almost white, crystalline powder, soluble in water; very slightly soluble in ethanol (96%) and in ether. Name: (1_RS_,2_SR_)-2-phenyl-cyclopropylamine sulphate Molecular formula: (C 9 H 11 N) 2 ,H 2 SO 4 Molecular weight: 364.5 PHARMACOLOGY Tranylcypromine is a non-hydrazine monoamine oxidase inhibitor with a rapid onset of activity. It increases the concentration of adrenaline, noradrenaline, and serotonin in storage sites throughout the nervous system, and in theory, this increased concentration of monoamines in the brainstem is the basis for its antidepressant activity. When tranylcypromine is withdrawn, monoamine oxidase activity is recovered in 3 to 5 days, although the drug is excreted in 24 hours. INDICATIONS Parnate is indicated for the treatment of Major Depression. 2 • H 2 SO 4 PARNATE PRODUCT INFORMATION 2 of 9 Version 2.1 CONTRAINDICATIONS BECAUSE THE EFFECT OF MANY ANTIDEPRESSANT DRUGS MAY PERSIST FOR SEVERAL DAYS, DO NOT COMMENCE PARNATE THERAPY WITHIN LESS THAN A WEEK OF DISCONTINUING TREATMENT WITH SUCH DRUGS. THEN USE HALF THE NORMAL DOSAGE FOR THE FIRST WEEK. SIMILARLY, ALLOW AT LEAST A WEEK TO ELAPSE Leer el documento completo